HEARTBEAM, INC.

BEAT ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Operating Activities
Net Income $-21.0M $-19.4M $-14.6M $-13.0M $-4.4M $-1.1M
Depreciation & Amortization
Depreciation $40.0K $7.0K $0
Amortization
Stock-Based Compensation $5.1M $4.3M $3.2M $1.1M $192.0K $10.0K
Net Cash from Operating Activities $-14.0M $-14.5M $-12.1M $-9.9M $-3.2M $-600.0K
Investing Activities
Capital Expenditures $600.0K $201.0K $256.0K $0
Business Acquisitions
Net Cash from Investing Activities $-600.0K $-201.0K $-256.0K $0
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $16.6M $866.0K $25.0M $350.0K $16.4M $619.0K
Net Change in Cash $2.0M $-13.8M $12.6M $-9.6M $13.2M $19.0K
Free Cash Flow $-14.6M $-14.7M $-12.3M $-9.9M